Modernizing Global Health Security to Prevent, Detect, and Respond explores―through thoughtful, thorough, and diverse scientific review and analyses―factors that have led to recent public health emergencies and offers a vision for a better protected global environment. The authors consider the history of global health security, governance, and legal structures with an eye toward novel approaches for the present and future. The book presents a vision for a more protected and safer global public health future (with the actions needed to achieve it) to prevent, detect, and respond to (re)emerging threats. Its aim is to chart a way forward with the understanding that future pandemics must and can be prevented. Major topics examined from a public health perspective include global health security; the growing concept of One Health; epidemic and pandemic prevention, detection, and response; reviews of past (e.g., Ebola, MERS-CoV, Zika, and COVID-19) public health emergencies of international concern; roles of information and communication technology; humanmade public health threats; and legal and ethical issues (e.g., viral sovereignty, trust, and transparency). Modernizing Global Health Security to Prevent, Detect, and Respond provides the academic substance and quality for researchers and practitioners to deeply understand the why of health emergencies, and most importantly―what we can and should do now to prepare.
- Highlights (re)emerging past and future threats to public health (e.g., climate change, antibiotic resistance, failures of societal sectors to work together)
- Discusses new visions for global health security in each chapter
- Considers how to leverage technological innovations to advance public health
- Includes practical examples through case studies from around the world
Prior to joining the Epidemic Intelligence Service (EIS) and serving the 2-year EIS residency in New Orleans, LA, Dr. McNabb PhD, MS, worked for 13 years at the Oklahoma State Health Department. Since 1993, most of his professional efforts have focused on supporting those in underdeveloped, underserved global settings. Before retirement from CDC in 2010, he served as Associate Director for Science; Public Health Informatics and Technology Program Office; Office for Surveillance, Epidemiology, and Laboratory Services. From 2006 – 2008, he directed the Division of Integrated Surveillance Systems and Services, National Center for Public Health Informatics, CDC. He is Research Professor and Director of the King Abdullah Fellowship Program (http://kingabdullahfellowship.com) at Emory University, Rollins School of Public Health. Teaching two classes, GH 504 Effective Oral Presentations for Public Health Professionals and GH 592 Successful Scientific Writing for Public Health Professionals, he also teaches in a short-course format: Successful Scientific Writing and Effective Oral Communications and in the University of Michigan Graduate Summer Session. Having mentored 19 students through their M.P.H. or Ph.D., plus 14 fellows through the CDC Public Health Prevention Specialists program, he is jointly appointed in the Hubert Department of Global Health and Department of Epidemiology. He holds an appointment as Adjunct Professor, Department of Epidemiology and Biostatistics, College of Public Health and Health Informatics, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Kingdom of Saudi Arabia. Promoted to Distinguished Consultant in 2005 and nominated for the 2005 CDC Charles C. Shepard Award, he completed the 2004 Senior Executive Services (SES) candidate development program and is certified by the Office of Personnel Management. Dr. McNabb serves on the Editorial Board, Epidemiology and Global Health and in private practice as a Board Member of Ascel Bio, LLC; Senior Consultant and Managing Partner, Public Health Practice, LLC (http://www.publichealthpractice.com); and Senior Consultant, Global Strategies, LLC (http://www.global-strategies.net).
Affan T. Shaikh is a public health professional with interests in disease prevention and health systems strengthening. With over seven years of professional experience, Affan’s work engages multilateral stakeholders including inter- and intra- governmental organizations, academic intuitions, NGOs, and communities in building local public health capacities, improving health outcomes, and increasing access. He has worked on the ground across 22 different countries, and during the peak of the MERS-CoV outbreak in Saudi Arabia and following the Ebola epidemic in Sierra Leone. More recently he has supported the Africa CDC with their COVID-19 response through innovative public health applications. Through his work, Affan is driven to strengthen health systems using evidence-based research. He has had numerous teaching engagements with Emory University, the University of Michigan, and Columbia University, where he has taught courses on public health surveillance, oral communication, and scientific writing.
He has successfully consulted with the US Centers for Disease Control and Prevention, the Africa Centers for Disease Control and Prevention, numerous Ministries of Health throughout Africa, the Middle East, and South Asia, and the World Health Organization. In addition to consulting, he serves as a Visiting Scientist for the National Academy of Sciences and as an International Board Member to the Saudi Arabia Centres for Disease Control and Prevention. Affan holds an MPH in International Health from Boston University and a BA in Economics from the University of California, Los Angeles.
Carol Haley, PhD, is currently an Adjunct Associate Professor in the Rollins School of Public Health, Hubert Department of Global Health at Emory University. She has spent nearly 30 years working at the intersection of science and policy in various capacities in industry, government, and academia. Her experience includes, among others, positions at the Virginia Water Resources Research Center where she researched and wrote about legal, scientific, economic, and social aspects of issues concerning Virginia’s waters; and at the Center for Veterinary Medicine at the US Food and Drug Administration, first specializing in environmental impacts of animal drugs, and later, as the Center’s Deputy Associate Director of Policy and Regulations, developing animal drug policy. She has extensive experience in US regulatory affairs and policy, environmental policy, and freshwater ecology. Her volunteer activities include having served on the Board of Trustees of Randolph College and on the Vestry of the Church of the Holy Trinity in NYC. She received her doctorate in biology from Virginia Tech in Blacksburg, Virginia, US.
